Suetsugu K et al. |
Analysis of the variable factors influencing tacrolimus blood concentration during the switch from continuous intravenous infusion to oral administration after allogeneic hematopoietic stem cell transplantation. |
2017 |
Int. J. Hematol. |
pmid:27822915
|
Lim SW et al. |
Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. |
2017 |
Cell Death Dis |
pmid:28771227
|
Savaj S et al. |
Irreversible Lesions of Tacrolimus-induced Posterior Reversible Leukoencephalopathy Syndrome. |
2017 |
Iran J Kidney Dis |
pmid:29190599
|
Shahid S et al. |
Chronic hepatitis in the transplant patient. |
2017 |
Br J Hosp Med (Lond) |
pmid:28692371
|
Gao L et al. |
Synergistic Effects of Tacrolimus and Azoles against Exophiala dermatitidis. |
2017 |
Antimicrob. Agents Chemother. |
pmid:28923863
|
Liang Q et al. |
The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy. |
2017 |
Ren Fail |
pmid:28562168
|
Jin H et al. |
Inappropriate amounts of topical tacrolimus applied on Korean patients with eczema. |
2017 |
J Dermatolog Treat |
pmid:27588441
|
Seo SR et al. |
Disrupted Skin Barrier is Associated with Burning Sensation after Topical Tacrolimus Application in Atopic Dermatitis. |
2017 |
Acta Derm. Venereol. |
pmid:28512670
|
Shen CL et al. |
Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft Rejection. |
2017 |
Sci Rep |
pmid:28512328
|
Egeland EJ et al. |
High Tacrolimus Clearance Is a Risk Factor for Acute Rejection in the Early Phase After Renal Transplantation. |
2017 |
Transplantation |
pmid:28452920
|
Aktürk S et al. |
Average Tacrolimus Trough Level in the First Month After Transplantation May Predict Acute Rejection. |
2017 |
Transplant. Proc. |
pmid:28340806
|
Vanhove T et al. |
Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype. |
2017 |
Pharmacogenomics J. |
pmid:27378609
|
Riva N et al. |
Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus. |
2017 |
Farm Hosp |
pmid:28236795
|
Størset E et al. |
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation. |
2017 |
Br J Clin Pharmacol |
pmid:28146606
|
Lewis K et al. |
Autoimmune enteropathy and hepatitis in pediatric heart transplant recipient. |
2017 |
Pediatr Transplant |
pmid:28097735
|
Hayes W et al. |
Hypomagnesemia and increased risk of new-onset diabetes mellitus after transplantation in pediatric renal transplant recipients. |
2017 |
Pediatr. Nephrol. |
pmid:28039534
|
Hu Y et al. |
FK506 suppresses hypoxia‑induced inflammation and protects tight junction function via the CaN‑NFATc1 signaling pathway in retinal microvascular epithelial cells. |
2017 |
Mol Med Rep |
pmid:28901449
|
Kalt DA |
Tacrolimus: A Review of Laboratory Detection Methods and Indications for Use. |
2017 |
Lab Med |
pmid:29096030
|
Andrews LM et al. |
Pharmacokinetic considerations related to therapeutic drug monitoring of tacrolimus in kidney transplant patients. |
2017 |
Expert Opin Drug Metab Toxicol |
pmid:29084469
|
Vanhove T et al. |
Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation. |
2017 |
Br J Clin Pharmacol |
pmid:28603840
|